Literature DB >> 30737043

Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course.

Joss Kessels1, Arnaud Tarantola2, Naseem Salahuddin3, Lucille Blumberg4, Lea Knopf5.   

Abstract

Rabies is a fatal zoonotic disease preventable through timely and adequate post-exposure prophylaxis (PEP) to potentially exposed persons i.e. wound washing and antisepsis, a series of intradermal (ID) or intramuscular (IM) rabies vaccinations, and rabies immunoglobulin in WHO category III exposures. The 2010 WHO position on rabies vaccines recommended PEP schedules requiring up to 5 clinic visits over the course of approximately one month. Abridged schedules with less doses have potential to save costs, increase patient compliance, and thereby improve equitable access to life-saving PEP for at-risk populations. We systematically reviewed new evidence since that considered for the 2010 position paper to evaluate (i) the immunogenicity and effectiveness of PEP schedules of reduced dose and duration; (ii) new evidence on effective PEP protocols for special populations; and (iii) the effect of changing routes of administration (ID or IM) during a single course of PEP. Our search identified a total of 14 relevant studies. The identified studies supported a reduction in dose or duration of rabies PEP schedules. The 1-week, 2-site ID PEP schedule was found to be most advantageous, as it was safe, immunogenic, supported by clinical outcome data and involved the least direct costs (i.e. cost of vaccine) compared to other schedules. To supplement this evidence, as yet unpublished additional data were reviewed to support the strength of the recommendations. Evidence suggests that changes in the rabies vaccine product and/or the route of administration during PEP is possible. Few studies have evaluated PEP schedules in persons with suspect or confirmed rabies exposures. Gaps exist in understanding the safety and immunogenicity of novel PEP schedules in special populations such as infants and immunocompromised individuals. Available data indicate that administering rabies vaccines during pregnancy is safe and effective.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Post-exposure prophylaxis; Rabies; Systematic literature review; Updated WHO position; Vaccine

Mesh:

Substances:

Year:  2019        PMID: 30737043     DOI: 10.1016/j.vaccine.2019.01.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study.

Authors:  Ravish H S; Akash Khobragade; Durga Satapathy; Monica Gupta; Surendra Kumar; Vinay Bhomia; Ramasubramanian V; Maharshi Desai; Ashok Dilipkumar Agrawal
Journal:  Hum Vaccin Immunother       Date:  2021-09-09       Impact factor: 4.526

Review 2.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

3.  Neuroglia infection by rabies virus after anterograde virus spread in peripheral neurons.

Authors:  Madlin Potratz; Luca M Zaeck; Carlotta Weigel; Antonia Klein; Conrad M Freuling; Thomas Müller; Stefan Finke
Journal:  Acta Neuropathol Commun       Date:  2020-11-23       Impact factor: 7.801

4.  Rabies encephalitis in a preschool child following postexposure prophylaxis.

Authors:  K M Chaitra; Sandeep Ballal; N R Ramesh Masthi; D H Ashwath Narayana; H T Yashodha; Mansi Kumar; Afroza Asiya; Divya Bharathi G; Sanjay S C
Journal:  PLoS Negl Trop Dis       Date:  2021-02-18

5.  Lean Management Promotes Compliance and Satisfaction of Rabies Vaccines.

Authors:  Miao-Miao Zhang; Xiao-Chun Yu; Feng-Li Lu; Ke-Ke Lu
Journal:  Patient Prefer Adherence       Date:  2021-06-03       Impact factor: 2.711

6.  A shorter post-exposure prophylaxis regimen for rabies, Pakistan.

Authors:  Naseem Salahuddin; Nadia Ansari; Muhammad Aftab Gohar
Journal:  Bull World Health Organ       Date:  2021-04-29       Impact factor: 9.408

Review 7.  [New aspects of rabies control].

Authors:  H Bourhy; G D de Melo; A Tarantola
Journal:  Bull Acad Natl Med       Date:  2020-09-18       Impact factor: 0.144

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.